Global Polio (Poliomyelitis) Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Polio (Poliomyelitis) Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Polio vaccines are vaccines used to prevent poliomyelitis. There are two typesone that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2025.
Polio (Poliomyelitis) Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Polio (Poliomyelitis) Vaccines market is projected to reach US$ 835.1 million in 2034, increasing from US$ 709.8 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from Research & Academic Laboratories and Pharmaceutical & Biotechnology Companies are the major drivers for the industry.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 100% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Polio (Poliomyelitis) Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Polio (Poliomyelitis) Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Polio (Poliomyelitis) Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Polio (Poliomyelitis) Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Polio (Poliomyelitis) Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Polio (Poliomyelitis) Vaccines introduction, etc. Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Polio (Poliomyelitis) Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2025.
Polio (Poliomyelitis) Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Polio (Poliomyelitis) Vaccines market is projected to reach US$ 835.1 million in 2034, increasing from US$ 709.8 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from Research & Academic Laboratories and Pharmaceutical & Biotechnology Companies are the major drivers for the industry.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 100% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Polio (Poliomyelitis) Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Polio (Poliomyelitis) Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Polio (Poliomyelitis) Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Polio (Poliomyelitis) Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Polio (Poliomyelitis) Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Polio (Poliomyelitis) Vaccines introduction, etc. Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Polio (Poliomyelitis) Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices